Epoch Biodesign Secures €10.3 Million to Revolutionize Recycling with AI and Enzymes

In a significant stride toward sustainable innovation, London-based biotech startup Epoch Biodesign has successfully raised €10.3 million ($12 million) in a fresh funding round. This financial boost aims to accelerate the commercial rollout of their groundbreaking enzymatic recycling technology, specifically for nylon 6,6—a material integral to both the apparel and automotive industries.

Pioneering a Circular Economy

Epoch Biodesign is at the forefront of a new era in recycling, combining the power of artificial intelligence with advanced synthetic biology. Founded in 2019, the company has set its sights on transforming how we manage plastic and textile waste, moving from pilot-scale operations to commercial-scale production. Their proprietary enzymatic process promises to recycle end-of-life products into virgin-quality materials, significantly reducing environmental impact.

Strategic Investment and Industry Support

The latest funding round saw participation from notable investors including Lululemon, KOMPAS VC, Happiness Capital, Extantia, and Leitmotif, adding to the €17 million raised in an earlier Series A round. With a total capital raise exceeding €43.1 million ($50 million), Epoch is well-positioned to expand its operations and refine its technology.

Jacob Nathan, Epoch’s Founder and CEO, emphasized the potential impact of their innovations: “Nylon 6,6 is a key material for both apparel and automotive industries, but a circular solution has yet to be successful at scale. Support from partners such as these highlights Epoch’s momentum and will accelerate our plans to progress from multi-tonne production to multi-kilotonne scale.”

Transformative Technology

Epoch's revolutionary platform employs AI-designed enzymes capable of breaking down materials at the molecular level. This allows for the continuous recycling of materials that would typically end up in landfills or incinerators. The company's process transforms waste garments and nylon materials back into their original chemical components—adipic acid and HMDA—enabling the production of new, virgin-quality polymers and yarns.

The startup's technology also offers a versatile solution for processing blended textiles, multi-layer laminates, coated fibers, and various mixed automotive plastics. This adaptability positions Epoch as a leader in the sustainable materials sector.

Implications for the Startup Ecosystem

Epoch Biodesign's progress holds significant implications for startups and investors in the sustainability space. By demonstrating the commercial viability of enzymatic recycling, Epoch is paving the way for a new wave of eco-friendly innovations. For investors, this represents an opportunity to support a technology with substantial environmental and economic potential.

A Promising Future

As Epoch Biodesign transitions from pilot production to a larger demonstration site, the new funding will be instrumental in validating their commercial-scale operations. The company is also nearing the completion of its largest nylon 6,6 biorecycling facility, further solidifying its position in the market.

The collaboration with INVISTA, a global leader in nylon production, underscores the strategic alliances Epoch is forging to enhance supply chain sustainability. By providing a drop-in solution that integrates seamlessly with existing supply chains, Epoch enables brands and OEMs to improve sustainability without altering their suppliers.

Epoch Biodesign’s journey illustrates the transformative power of technology and innovation in addressing some of the world’s most pressing environmental challenges. As they continue to expand and refine their operations, the company stands as a beacon of what is possible in the pursuit of a sustainable future.

Source: EU-Startups